Next Article in Journal
2-[3,5-Bis(5-bromothien-2-yl)-4H-1,2,6-thiadiazin-4-ylidene]-malononitrile
Previous Article in Journal
Microwave-Assisted Synthesis of 1-(5-Substituted-4-hydroxy-2-methyl-1H-pyrrol-3-yl)ethan-1-ones from 2-Amino Acid-Derived Enamine-Type Schiff Bases
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

3-(4-Ethynylphenyl)-1,5-diphenylformazan

by
Ida A. Lupanova
1,
Dzhamilya N. Konshina
1,
Igor V. Sukhno
2,
Ekaterina S. Spesivaya
1 and
Valery V. Konshin
1,*
1
Department of Chemistry and High Technology, Kuban State University, 149 Stavropolskaya Str., 350040 Krasnodar, Russia
2
Nanobiotechnology Department, Kuban State Agrarian University, 13 Kalinina Str., 350044 Krasnodar, Russia
*
Author to whom correspondence should be addressed.
Molbank 2025, 2025(1), M1976; https://doi.org/10.3390/M1976
Submission received: 10 February 2025 / Revised: 19 February 2025 / Accepted: 24 February 2025 / Published: 3 March 2025
(This article belongs to the Section Structure Determination)

Abstract

:
The structure of the “clickable” formazan, 3-(4-ethynylphenyl)-1,5-diphenylformazan, has been determined for the first time in a single crystal. The synthesis of 3-(4-ethynylphenyl)-1,5-diphenylformazan was carried out by coupling 4-(trimethylsilyl)ethynylbenzaldehyde phenylhydrazone with diazotized aniline, followed by desilylation, with a total yield of 54%.

1. Introduction

The interest in formazans is due to the presence of a set of practically important properties, which are rarely manifested simultaneously in representatives of other classes of organic compounds [1,2,3,4,5]. Formazans can exhibit photo- and thermochromic properties, act as effective metal ligands or indicators of redox processes, and also demonstrate various types of biological activity. Their applications include use as dyes, indicators, components of optical recording media and photographic compositions, and catalysts for oxidation–reduction reactions. Formazans are also applied in fine organic synthesis; they are particularly important as starting compounds for the synthesis of tetrazolium salts [6,7,8,9,10], verdazyls [11,12,13,14], and boratetrazines [15,16,17,18,19,20,21] (Figure 1), as well as various heterocycles [22,23].
The structural diversity of formazans is due to the ease of varying the three substituents in the azo-hydrazone chain. Of particular interest are “clickable” formazans, which can be used to synthesis conjugates with various molecules and to functionalize solid matrices. To date, several “clickable” formazans have been described [24,25,26,27,28,29,30] (Figure 2). One of the simplest compounds of this type, containing an ethynyl group in the meso position of the azo-hydrazone chain, is 3-(4-ethynylphenyl)-1,5-diphenylformazan 2, which was recently synthesized for the first time by coupling 4-ethynylbenzaldehyde phenylhydrazone with phenyldiazonium tosylate [27] and used for the synthesis of verdazyls.
The present work describes the synthesis of 3-(4-ethynylphenyl)-1,5-diphenylformazan and its crystal structure.

2. Results and Discussion

As the starting building block, we used the readily available compound 4-(trimethylsilyl)ethynylbenzaldehyde (8) [31], which is also a commercially available reagent ($6.03/1 g Macklin Inc., Rochelle, IL, USA). When compound 8 was reacted with phenylhydrazine in boiling ethanol, 1-phenyl-2-[4-((trimethylsilyl)ethynyl)benzylidene]hydrazine (10) was synthesized, with a yield of 74% (Scheme 1).
For the synthesis of formazan, a classical scheme was chosen involving the condensation of the phenylhydrazone with the diazonium salt in a pyridine medium in the presence of glacial acetic acid. The reaction was carried out at −5 °C (Scheme 2). According to TLC data, the product (12) formed is sufficiently pure and does not require additional purification.
Desilylation of 12 was performed using potassium hydroxide in methanol at room temperature (Scheme 3).
The structure of products 10, 12, and 2 was confirmed by 1H, 13C NMR, IR spectroscopy and mass spectrometry.
The structure of 3-(4-ethynylphenyl)-1,5-diphenylformazan (2) was unambiguously confirmed by single-crystal X-ray analysis (Figure 3). The single crystals of 2 were grown by recrystallization of the title compound in ethanol.
Compound 2 crystallizes in the centrosymmetric orthorhombic space group Pbca. The whole molecule is non-planar, with the aryl rings slightly twisted with respect to the formazan plane N2N1C1N3N4. The dihedral angles between the aromatic planes C2–C7, C10–C15, C16–C21 and the plane N2N1C1N3N4 are 5.8 °, 10.2 °, and 15.4 °, respectively. The formazan system has the syn,s-cis configuration, which is characteristic of some other triaryl substituted formazans [16,17]. The difference between the lengths of the double and single bonds in the formazan moiety is reduced, indicating π-electron density delocalization (e.g., N4 = N3 1.288 (1) Å, N1–N2 1.314 (1) Å). A similar distribution of bond lengths is observed in other triaryl-substituted formazans (e.g., CSD refcodes: PEVWET [16], PUVCOA [17]). Thus, the ethynyl substituent does not affect the structure of the formazan moiety but makes the arrangement of the aryl rings more twisted compared to the PEVWET [16] and PUVCOA [17], probably due to the packing features of the ethynyl compound. The hydrogen atom of the NH group is refined as disordered over two positions with occupancies of 0.69 (2) for H2 and 0.31 (2) for H4A. The syn, s-cis configuration is stabilized by intramolecular hydrogen bonds N2–H2∙∙∙N4 (N2–H2 0.89 (2) Å, H2∙∙∙N4 1.86 (2) Å), and N4–H4A∙∙∙N2 (N4–H4A 0.89 (5) Å, H4A∙∙∙N2 1.87 (6) Å) for the minor disorder component.
In conclusion, 3-(4-ethynylphenyl)-1,5-diphenylformazan was synthesized, and its structure was confirmed by a combination of 1H, 13C NMR, IR spectroscopy, mass spectrometry, and X-ray diffraction data.

3. Materials and Methods

The reactions were monitored by thin-layer chromatography (Sorbfil, Imid Ltd., Krasnodar, Russia). The 1H-NMR and 13C-NMR spectra were acquired on ECA400 (JEOL, Tokyo, Japan) (400 and 100 MHz, respectively) spectrometers in CDCl3 and (CD3)2SO at room temperature. The chemical shifts δ were measured in ppm with reference to the residual solvent resonances (1H: CDCl3, δ = 7.25 ppm; 13C: CDCl3, δ = 77.2 ppm; 1H: (CD3)2SO, δ = 2.49 ppm; 13C: (CD3)2SO, δ = 39.5 ppm) or Me4Si. The splitting patterns are referred to as s, singlet; d, doublet; t, triplet; m, multiplet. Coupling constants (J) are given in hertz. IR spectra were recorded on an IR Prestige (Shimadzu, Kyoto, Japan), using tablets of samples with KBr. High-resolution and accurate mass measurements were carried out using a Bruker MaXis Impact (electrospray ionization/time of flight) (Bruker, Bremen,_Germany). The melting points were determined on a Stuart SMP30 apparatus and left uncorrected. X-ray diffraction investigation of compound 2 was conducted using an automatic diffractometer Bruker Apex DUO (CuKα radiation, ω- and φ-scanning). Empirical absorption correction and systematic error correction were performed using the SADABS program [32]. The structure was deciphered by direct methods and refined using the least squares method in the anisotropic full-matrix approximation based on F2hkl. The positions of hydrogen atoms bonded to nitrogen atoms and the carbon atom of the acetylene fragment were determined from difference Fourier syntheses of electron density, while the positions of the remaining hydrogen atoms were calculated. All hydrogen atoms, except for the one bonded to the nitrogen atom, were refined in the riding model with Uiso(H) = 1.2Ueq(C). All calculations were performed using the SHELXTL PLUS software package [33].
The commercial reagents employed in the synthesis were 4-(trimethylsilyl)ethynylbenzaldehyde (95%, Manchester Organics Ltd., Runcorn, UK), Phenylhydrazine (for synthesis, ≥97%, Aldrich, St. Louis, MO, USA), and aniline (≥99%, Vekton, Saint Petersburg, Russia).

3.1. 1-Phenyl-2-[4-((trimethylsilyl)ethynyl)benzylidene]hydrazine (10)

In a reflux flask with a condenser, 20 mL of ethanol, 1 g (4.94 mmol) of 4-(trimethylsilyl)ethynylbenzaldehyde, and 485 µL (4.94 mmol) of phenylhydrazine were added and heated for 20 min. The reaction mixture was cooled to 3 °C for crystallization. The precipitate was filtered and washed with a small amount of cold ethanol.
Yield: 1.07 g (74%); beige crystals; mp 132-135 °C. IR (KBr): ν = 3311 (NH), 3078, 3049, 3034 (Csp2-H), 2954, 2897 (Csp3-H), 2154 (Csp-Csp), 1598, 1589, 1523, 1494 (Csp2-Csp2), 1444, 1408, 1355, 1313, 1296, 1261, 1249, 1222, 1134, 1102, 1068, 920, 864, 846, 835 cm−1 (SI, Figure S1). 1H NMR (CDCl3, 399.78 MHz): δ = 0.26 (s, 9H, CH3), 6.86–6.90 (m, 1H, CH), 7.08–7.12 (m, 2H, CH), 7.24–7.30 (m, 2H, CH), 7.43–7.46 (m, 2H, CH), 7.55–7.59 (m, 2H, CH + 1H CH) (SI, Figure S2). 13C NMR (CDCl3, 100.5 MHz): δ = −0.03 (CH3), 95.4 (Csp), 105.1 (Csp), 112.8 (CH), 120.3 (CH), 122.7 (C), 125.8 (CH), 129.3 (CH), 132.2 (CH), 135.4 (C), 136.2 (CHimine), 144.3 (C) (SI, Figure S3). UV–VIS λmax, nm (Irel, %): 252 (6671), 372 (11396). HRMS ESI TOF: m/z = 293.1476 [M+H]+ (293.1468 calcd. for C18H21N2Si) (SI, Figure S4).

3.2. 1,5-Diphenyl-3-[4-((trimethylsilyl)ethynyl)phenyl]formazan (12)

To a solution of 0.46 g (1.57 mmol) of 1-phenyl-2-[4-((trimethylsilyl)ethynyl)benzylidene]hydrazine in 15 mL of pyridine and 0.5 mL of glacial acetic acid, a solution of phenyl diazonium chloride, synthesized from 143 µL (1.57 mmol) of aniline, 0.108 g (1.57 mmol) of NaNO2, and 1.2 mL of 37% HCl in 1 mL of water, was added at −5 °C. The resulting cherry–red reaction mixture with precipitate was maintained for 30 min at −5 °C, and then for 1 h at room temperature. The reaction mixture was then poured into 150 mL of 2M HCl, and the precipitate was filtered and washed with water. Yield: 525 mg (84%); cherry–red powder; mp 193-195 °C. Rf = 0.41 (Hexane–EtOAc 10:1). IR (KBr): ν = 3084, 3064, 3049, 3032 (Csp2-H), 2954 (Csp3-H), 2152 (Csp-Csp), 1597, 1506, 1498 (Csp2-Csp2), 1452, 1404, 1354, 1313, 1249, 1236, 1186, 1074, 1035, 866, 842 cm−1 (SI, Figure S5). 1H NMR (CDCl3, 399.78 MHz): δ = 0.28 (s, 9H, CH3), 7.26–7.30 (m, 2H, CH), 7.43–7.47 (m, 4H, CH), 7.51–7.53 (m, 2H, CH), 7.65–7.67 (m, 4H, CH), 8.06–8.08 (m, 2H, CH), 15.51 (s, 1H, NH) (SI, Figure S6). 13C NMR (CDCl3, 100.5 MHz): δ = 0.06 (CH3), 94.8 (Csp), 105.5 (Csp), 118.8 (CH), 122.0 (C), 125.3 (CH), 127.7 (CH), 129.4 (CH), 132.1 (CH), 137.5 (C), 140.4 (C), 147.7 (C) (SI, Figure S7). UV-VIS λmax, nm (Irel, %): 252 (6671), 372 (11396). HRMS ESI TOF: exact mass found 397.1842 (397.1842 calcd. for C24H23N4Si) (SI, Figure S8).

3.3. 3-(4-Ethynylphenyl)-1,5-diphenylformazan (2)

To 300 mg (0.76 mmol) of 1,5-diphenyl-3-[4-((trimethylsilyl)ethynyl)phenyl]formazan in 20 mL of MeOH, 420 mg (3.04 mmol) of finely ground K2CO3 was added. The reaction mixture was stirred at room temperature for 4 h. Then, the reaction mixture was poured into 100 mL of 2M HCl, and the precipitate was filtered and washed with water. Yield: 214 mg (87%); purple–black needles; mp 205-207 °C. Rf = 0.41 (Hexane–EtOAc 10:1). IR (KBr): ν = 3278 (Csp-H), 3062, 3045, 3030 (Csp2-H), 2096 (Csp-Csp), 1597, 1500 (Csp2-Csp2), 1450, 1406, 1354, 1313, 1238, 1184, 1163, 1147, 1072, 1033, 1012, 839 cm−1 (SI, Figure S9). 1H NMR ((CD3)2SO, 399.78 MHz): δ = 7.32–7.36 (m, 2H, CH), 7.49–7.57 (m, 6H, CH), 7.85–7.87 (m, 2H, CH), 8.01–8.04 (m, 2H, CH), 14.42 (s, 1H, NH) (SI, Figure S10). 13C NMR ((CD3)2SO, 100.5 MHz): δ = 81.6 (Csp), 83.6 (Csp), 119.1 (CH), 120.8 (C), 126.0 (CH), 127.8 (CH), 129.5 (CH), 131.9 (CH), 136.5 (C), 140.6 (C), 147.5 (C) (SI, Figure S11). UV-VIS λmax, nm (Irel, %): 252 (6671), 372 (11396). MS (EI, 70 eV), m/z (Irel, %): 324 [M+] (100), 247 (4), 219 (41), 92 (31), (SI, Figure S12). HRMS ESI TOF: exact mass found 323.1277 (exact mass calculated for C21H14N4 323.1291) (SI, Figure S13).
Crystal data for C21H16N4 (M = 324.38 g/mol): Orthorhombic, space group Pbca, a = 7.89300(10) Å, b = 18.6508(3) Å, c = 22.6827(3) Å, α = 90°, β = 90°, γ = 90°, V = 3339.14(8) Å3, Z = 8, T = 120 K, μ = 6.21 cm−1, Dcalc. = 1.290 Mg/m3. In total, 24,973 reflections were measured, 3221 of which were unique and used in all calculations. The final R1 was 0.0342, and the wR2 was 0.0913 (all data) (SI, Tables S1–S7). CCDC 2,410,636 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge at http://www.ccdc.cam.ac.uk/or (accessed on 29 November 2021) from the CCDC, 12 Union Road, Cambridge CB2 1EZ, UK; Fax: +44-1223-336033; E-mail: deposit@ccdc.cam.ac.uk.

Supplementary Materials

Figure S1: IR spectrum 1-phenyl-2-(4-((trimethylsilyl)ethynyl)benzylidene)hydrazine; Figure S2: 1H NMR 1-phenyl-2-(4-((trimethylsilyl)ethynyl)benzylidene)hydrazine; Figure S3: 13C NMR spectrum 1-phenyl-2-(4-((trimethylsilyl)ethynyl)benzylidene)hydrazine; Figure S4: HRMS 1-phenyl-2-(4-((trimethylsilyl)ethynyl)benzylidene)hydrazine; Figure S5: IR spectrum 1,5-diphenyl-3-(4-((trimethylsilyl)ethynyl)phenyl)formazan; Figure S6: 1H NMR 1,5-diphenyl-3-(4-((trimethylsilyl)ethynyl)phenyl)formazan; Figure S7: 13C NMR 1,5-diphenyl-3-(4-((trimethylsilyl)ethynyl)phenyl)formazan; Figure S8: HRMS 1,5-diphenyl-3-(4-((trimethylsilyl)ethynyl)phenyl)formazan; Figure S9: IR spectrum 3-(4-ethynylphenyl)-1,5-diphenylformazan; Figure S10: 1H NMR 3-(4-ethynylphenyl)-1,5-diphenylformazan; Figure S11: 13C NMR 3-(4-ethynylphenyl)-1,5-diphenylformazan; Figure S12: MS 3-(4-ethynylphenyl)-1,5-diphenylformazan; Figure S13: HRMS 3-(4-ethynylphenyl)-1,5-diphenylformazan; Figure S14: TLC (Hexane–EtOAc 10:1); (12–left, 2-right); Table S1: Crystal data and structure refinement for 2; Table S2: Atomic coordinates (× 104) and equivalent isotropic displacement parameters (Å2 × 103) for 2. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor; Table S3: Bond lengths [Å] and angles [°] for 2; Table S4: Anisotropic displacement parameters (Å2 × 103) for 2. The anisotropic displacement factor exponent takes the form: −2p2[h2a*2U11 + … + 2 h k a* b* U12]; Table S5: Hydrogen coordinates (× 104) and isotropic displacement parameters (Å2 × 103) for 2; Table S6: Torsion angles [°] for 2; Table S7: Hydrogen bonds for KV-F1 [Å and °].

Author Contributions

Conceptualization, V.V.K.; methodology, V.V.K. and D.N.K.; software, I.V.S. and D.N.K.; validation, V.V.K. and D.N.K.; formal analysis, D.N.K. and I.V.S.; investigation, I.A.L. and E.S.S.; resources, I.A.L. and E.S.S.; data curation, V.V.K.; writing—original draft preparation, V.V.K. and D.N.K.; writing—review and editing, V.V.K. and D.N.K.; supervision, V.V.K.; project administration, V.V.K.; funding acquisition, V.V.K., D.N.K., I.A.L. and E.S.S. All authors have read and agreed to the published version of the manuscript.

Funding

This publication was financially supported by the Russian Ministry of Education and Science (project no. FZEN-2023-0006).

Data Availability Statement

Data available from the corresponding authors upon reasonable request.

Acknowledgments

The HRMS study was accomplished with the use of scientific equipment of the Collective Employment Centre “Ecoanalytical Centre”, Kuban State University (A. Z. Temerdashev).

Conflicts of Interest

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Sigeikin, G.I.; Lipunova, G.N.; Pervova, I.G. Formazans and their metal complexes. Russ. Chem. Rev. 2006, 75, 885–900. [Google Scholar] [CrossRef]
  2. Lipunova, G.N.; Fedorchenko, T.G.; Chupakhin, O.N. New Aspects of the Chemistry of Formazans. Russ. J. Gen. Chem. 2019, 89, 1225–1245. [Google Scholar] [CrossRef]
  3. Gilroy, J.B.; Otten, E. Formazanate coordination compounds: Synthesis, reactivity, and applications. Chem. Soc. Rev. 2020, 49, 85–113. [Google Scholar] [CrossRef] [PubMed]
  4. Singh, N.; Sohal, H.S.; Verma, M.; Sharma, R.; Kaur, M. Synthesis and bio-activity of complex azo compounds: A review on formazans and its complexes. Main Group Chem. 2024, 23, 41–72. [Google Scholar] [CrossRef]
  5. Shawali, A.S.; Samy, N.A. Functionalized formazans: A review on recent progress in their pharmacological activities. J. Adv. Res. 2015, 6, 241–254. [Google Scholar] [CrossRef]
  6. Xu, Z.; Sung, Y.-S.; Tomat, E. Design of Tetrazolium Cations for the Release of Antiproliferative Formazan Chelators in Mammalian Cells. J. Am. Chem. Soc. 2023, 145, 15197–15206. [Google Scholar] [CrossRef]
  7. Ghasemi, M.; Turnbull, T.; Sebastian, S.; Kempson, I. The MTT Assay: Utility, Limitations, Pitfalls, and Interpretation in Bulk and Single-Cell Analysis. Int. J. Mol. Sci. 2021, 22, 12827. [Google Scholar] [CrossRef]
  8. Stockert, J.C.; Horobin, R.W.; Colombo, L.L.; Blázquez-Castro, A. Tetrazolium salts and formazan products in Cell Biology: Viability assessment, fluorescence imaging, and labeling perspectives. Acta Histochem. 2018, 120, 159–167. [Google Scholar] [CrossRef]
  9. Grela, E.; Kozłowska, J.; Grabowiecka, A. Current methodology of MTT assay in bacteria—A review. Acta Histochem. 2018, 120, 303–311. [Google Scholar] [CrossRef]
  10. Gavazov, K.B.; Dimitrov, A.N.; Lekova, V.D. The use of tetrazolium salts in inorganic analysis. Russ. Chem. Rev. 2007, 76, 169–179. [Google Scholar] [CrossRef]
  11. Teslenko, F.E.; Fershtat, L.L. Unlocking Kuhn Verdazyls: New Synthetic Approach and Useful Mechanistic Insights. Int. J. Mol. Sci. 2023, 24, 2693. [Google Scholar] [CrossRef]
  12. Lipunova, G.N.; Fedorchenko, T.G.; Chupakhin, O.N. Verdazyls: Synthesis, properties, application. Russ. Chem. Rev. 2013, 82, 701–734. [Google Scholar] [CrossRef]
  13. Lipunova, G.N.; Fedorchenko, T.G.; Tsmokalyuk, A.N.; Chupakhin, O.N. Advances in verdazyl chemistry. Russ. Chem. Bull. 2020, 69, 1203–1222. [Google Scholar] [CrossRef]
  14. Lipunova, G.N.; Fedorchenko, T.G.; Chupakhin, O.N. Verdazyls in Coordination Chemistry. Russ. J. Coord. Chem. 2022, 48, 397–411. [Google Scholar] [CrossRef]
  15. Stepanov, B.I.; Avramenko, G.V. Boron—Nitrogen compounds I. Reactions of triarylformazans with diboron tetraacetate. Synthesis of boratetrazines. J. Gen. Chem. (USSR) 1980, 50, 292–295. [Google Scholar]
  16. Gilroy, J.B.; Ferguson, M.J.; McDonald, R.; Patrick, B.O.; Hicks, R.G. Formazans as β-diketiminate analogues. Structural characterization of boratatetrazines and their reduction to borataverdazyl radical anions. Chem. Commun. 2007, 2, 126–128. [Google Scholar] [CrossRef]
  17. Barbon, S.M.; Price, J.T.; Reinkeluers, P.A.; Gilroy, J.B. Substituent-dependent optical and electrochemical properties of triarylformazanate boron difluoride complexes. Inorg. Chem. 2014, 53, 10585–10593. [Google Scholar] [CrossRef]
  18. Tikhonov, S.A.; Sidorin, A.E.; Samoilov, I.S.; Aleksandr, V.; Borisenko, A.V.; Vovna, V.I. Photoelectron spectra and electronic structure of boron diacetate formazanates. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2020, 238, 118441. [Google Scholar] [CrossRef]
  19. Buguis, F.L.; Hsu, N.; Sung, Y.; Sirohey, S.A.; Adam, M.C.; Goncharova, L.V.; Gilroy, J.B. Dyads and Triads of Boron Difluoride Formazanate and Boron Difluoride Dipyrromethene Dyes. Chem. A Eur. J. 2023, 29, e202302548. [Google Scholar] [CrossRef]
  20. Lupanova, I.A.; Konshina, D.N.; Elkov, N.A.; Konshin, V.V. 2-(4-(Dimethylamino)phenyl)-3,3-difluoro-4,6-diphenyl-3,4-dihydro-1,2,4,5,3-tetrazaborinin-2-ium-3-ide. Molbank 2022, 2022, M1312. [Google Scholar] [CrossRef]
  21. Yang, S.; Lu, K.; Xiao, H. Advancements in boron difluoride formazanate dyes for biological imaging. Curr. Opin. Chem. Biol. 2024, 81, 102473. [Google Scholar] [CrossRef] [PubMed]
  22. Buzykin, B.I. Formazans in the synthesis of heterocycles I. Synthesis of azoles (Review). Chem. Heterocycl. Comp. 2010, 46, 379–408. [Google Scholar] [CrossRef]
  23. Buzykin, B.I. Formazans in the synthesis of heterocycles. II. Synthesis of azines (Review). Chem. Heterocycl. Comp. 2010, 46, 1043–1062. [Google Scholar] [CrossRef]
  24. Dulog, L.; Breitenbucher, J. Darstellung eines (Diphenylverdazylylphenyl) propargylethers. Liebigs Ann. Chem. 1993, 1993, 201–202. [Google Scholar] [CrossRef]
  25. Lupanova, I.A.; Konshina, D.N.; Konshin, V.V. Clickable ionophores for the preparation of solid materials. AIP Conf. Proc. 2019, 2063, 040036. [Google Scholar] [CrossRef]
  26. Konshina, D.N.; Lupanova, I.A.; Chuprynina, D.A.; Konshin, V.V. Click functionalization in the synthesis of sorption materials. Communication I. Preparation and sorption characteristics of silicagel with immobilized formazan with regard to Pd(II) and Cu(II). Sorbtsionnye I Khromatograficheskie Protsessy 2018, 18, 568–578. [Google Scholar] [CrossRef]
  27. Votkina, D.E.; Petunin, P.V.; Zhivetyeva, S.I.; Bagryanskaya, I.Y.; Uvarov, M.N.; Kazantsev, M.S.; Trusova, M.E.; Tretyakov, E.V.; Postnikov, P.S. Preparation of Multi-spin Systems: A Case Study of Tolane-bridged Verdazyl-based Hetero-diradicals. Eur. J. Org. Chem. 2020, 2020, 1996–2004. [Google Scholar] [CrossRef]
  28. Magnan, F.; Dhindsa, J.S.; Anghel, M.; Bazylewski, P.; Fanchini, G.; Gilroy, J.B. A divergent strategy for the synthesis of redox-active verdazyl radical polymers. Polym. Chem. 2021, 12, 2786–2797. [Google Scholar] [CrossRef]
  29. Barbon, S.M.; Gilroy, J.B. Boron difluoride formazanate copolymers with 9,9-di-n-hexylfluorene prepared by copper-catalyzed alkyne–azide cycloaddition chemistry. Polym. Chem. 2016, 7, 3589–3598. [Google Scholar] [CrossRef]
  30. Barbon, S.M.; Novoa, S.; Bender, D.; Groom, H.; Luyt, L.G.; Gilroy, J.B. Copper-assisted azide–alkyne cycloaddition chemistry as a tool for the production of emissive boron difluoride 3-cyanoformazanates. Org. Chem. Front. 2017, 4, 178–190. [Google Scholar] [CrossRef]
  31. Thor, S.; Krause, N. Improved Procedures for the Palladium-Catalyzed Coupling of Terminal Alkynes with Aryl Bromides (Sonogashira Coupling). J. Org. Chem. 1998, 63, 8551–8553. [Google Scholar] [CrossRef]
  32. Sheldrick, G.M. SADABS v2008/4, Bruker Area Detector Absorption Correction Program. 2008. Available online: https://www.scienceopen.com/book?vid=5cab3651-c60c-4e6d-89cc-c55396e9e2dc (accessed on 9 February 2025).
  33. Sheldrick, G.M. A Short History of SHELX. Acta Crystallogr. Sect. A Found. Crystallogr. 2008, 64, 112–122. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Synthetic potential of formazans.
Figure 1. Synthetic potential of formazans.
Molbank 2025 m1976 g001
Figure 2. Some clickable formazans (1 [24,25,26], 2 [27], 3 [28], 4, 5 [29], 6, 7 [30]).
Figure 2. Some clickable formazans (1 [24,25,26], 2 [27], 3 [28], 4, 5 [29], 6, 7 [30]).
Molbank 2025 m1976 g002
Scheme 1. Reaction of 4-(trimethylsilyl)ethynylbenzaldehyde (8) with phenylhydrazine (9).
Scheme 1. Reaction of 4-(trimethylsilyl)ethynylbenzaldehyde (8) with phenylhydrazine (9).
Molbank 2025 m1976 sch001
Scheme 2. The reaction of 1-phenyl-2-[4-((trimethylsilyl)ethynyl)benzylidene]hydrazine (10) with phenyldiazonium chloride (11).
Scheme 2. The reaction of 1-phenyl-2-[4-((trimethylsilyl)ethynyl)benzylidene]hydrazine (10) with phenyldiazonium chloride (11).
Molbank 2025 m1976 sch002
Scheme 3. Desilylation of 1,5-diphenyl-3-[4-((trimethylsilyl)ethynyl)phenyl]formazan.
Scheme 3. Desilylation of 1,5-diphenyl-3-[4-((trimethylsilyl)ethynyl)phenyl]formazan.
Molbank 2025 m1976 sch003
Figure 3. Crystal structure of compound 2 with labeling schemes and 50% thermal ellipsoids.
Figure 3. Crystal structure of compound 2 with labeling schemes and 50% thermal ellipsoids.
Molbank 2025 m1976 g003
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Lupanova, I.A.; Konshina, D.N.; Sukhno, I.V.; Spesivaya, E.S.; Konshin, V.V. 3-(4-Ethynylphenyl)-1,5-diphenylformazan. Molbank 2025, 2025, M1976. https://doi.org/10.3390/M1976

AMA Style

Lupanova IA, Konshina DN, Sukhno IV, Spesivaya ES, Konshin VV. 3-(4-Ethynylphenyl)-1,5-diphenylformazan. Molbank. 2025; 2025(1):M1976. https://doi.org/10.3390/M1976

Chicago/Turabian Style

Lupanova, Ida A., Dzhamilya N. Konshina, Igor V. Sukhno, Ekaterina S. Spesivaya, and Valery V. Konshin. 2025. "3-(4-Ethynylphenyl)-1,5-diphenylformazan" Molbank 2025, no. 1: M1976. https://doi.org/10.3390/M1976

APA Style

Lupanova, I. A., Konshina, D. N., Sukhno, I. V., Spesivaya, E. S., & Konshin, V. V. (2025). 3-(4-Ethynylphenyl)-1,5-diphenylformazan. Molbank, 2025(1), M1976. https://doi.org/10.3390/M1976

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop